4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001737287-25-000003
EVP of R&D sold 27,199 shares at $1.78 ($48,414)
From the SEC's structured data for this filing
Trades in this filing
Roberts Zachary · EVP of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-21 | Sale : show line 1 in the form | −27,199 | $1.78 | $48,414 | 488,054 | D |
| Open-market sales · 27,199 sh · avg $1.78 · $48,414 | ||||||
Loading xslF345X05/wk-form4_1737667821.xml…